Today stock futures rise in premarket, after three days of losses.
Top stock gainers
Merck (MRK) shares jumped 5% after the FDA approved its therapy for people with pulmonary arterial hypertension, which consists of lung artery constriction. The authorized treatment, Winrevair, gives Merck another potential blockbuster. Winrevair costs $14,000 each vial, and most patients use one every three weeks, totaling $242,000 per year. Merck expects to introduce the medication in late April.
After reporting mixed Q4 profits and outlook, nCino (NCNO) shares rose 12%. The business expects Q1 revenues of $126M to $127M, below the average expectation of $128.83M. Subscription revenue is estimated to be $108.75M–$109.75M. Adjusted EPS is expected to exceed $0.12 per share at $0.13–$14. Revenue is expected to be $538.5M to $544.5M in FY2025, slightly below the average of $545.43M, with subscription revenue between $463M and $469M. Adjusted EPS to be $0.60–$0.64, above the consensus of $0.57.
DJT rose 10% in premarket trading on Wednesday after finishing 16% higher on its maiden trading day as a public company. Trump owns 78.75M business shares, worth $4.57B, according to regulatory records. Trump is its largest stakeholder with about 60%.
Robinhood Markets (HOOD) shares rose 6% after launching its first credit card with 3% reward on all purchases in the competitive market. Robinhood bought no-fee credit card company X1 for $95M last year to extend its products. Coastal Community Bank supplies the Robinhood Gold Card, which has no yearly or international transaction fees and is unique to Robinhood Gold customers. Robinhood Gold, a $50/year membership, gives better interest on uninvested funds, larger quick deposit limits, and a 3% IRA match. Robinhood Gold is also giving the first 5,000 users who recommend 10 individuals a 10-karat solid gold credit card.
Top stock losses
GameStop (GME) fell over 14% after missing holiday quarter estimates. Q4 hardware and accessory sales fell 12% to $1.09B, while software sales fell 31% to $465M. Seeking Alpha’s Quant rating system puts GME at high risk of poor performance due to growth and momentum problems.
Must read book about investing – check here Today’s Top Performers Today’s Top Performers Today’s Top Performers Today’s Top Performers
After reporting 8% Y/Y subscription revenue growth in 4Q24, DocuSign (NASDAQ:DOCU) shares rose 10%. Electronic signature business predicts 1Q25 revenue of $704M to $708M, above analysts’ $699.1M forecast. DocuSign expects sales of $2.91B to $2.92B this year, with consensus of $2.91B. Customer adoption of Contract Lifecycle Management and eSignature in StateRAMP-authorized environments was also emphasized by the organization.
MongoDB (NASDAQ:MDB) shares fell 8% after exceeding Q4 profit and sales forecasts owing to its dovish FY2025 outlook. MongoDB expects revenues of $436M to $440M in Q1, below the average expectation of $449.08M. Below the estimate of $0.61, non-GAAP EPS is expected to be $0.34–$0.39. The business estimates FY2024 sales between $1.9B and $1.93B, below the average of $2.03B. Unlike the consensus of $3.22, non-GAAP EPS is expected to be $2.27 to $2.49.
Marvell Technology (NASDAQ:MRVL) shares fell over 7% after solid Q4 earnings due to a dismal Q1 guidance. The business predicts Q1 sales of $1.15B, plus or less 5%, behind analysts’ $1.36B. Marvell predicts adjusted gross margins of 62% to 63% and adjusted earnings of $0.18 to $0.28 per share, significantly below the average forecast of $0.40. Marvell announced $3B in stock buybacks.
Despite a 5.7% Y/Y rise, Costco Wholesale’s NASDAQ:COST shares plummeted roughly 4% as its FQ2 earnings reports fell short of the top-line estimate. Comparable sales increased by 5.6% during the quarter, above the 5.1% estimate.
MongoDB (NASDAQ:MDB) shares fell 8% after exceeding Q4 profit and sales forecasts owing to its dovish FY2025 outlook. MongoDB expects revenues of $436M to $440M in Q1, below the average expectation of $449.08M. Below the estimate of $0.61, non-GAAP EPS is expected to be $0.34–$0.39. The business estimates FY2024 sales between $1.9B and $1.93B, below the average of $2.03B. Unlike the consensus of $3.22, non-GAAP EPS is expected to be $2.27 to $2.49.
Marvell Technology (NASDAQ:MRVL) shares fell over 7% after solid Q4 earnings due to a dismal Q1 guidance. The business predicts Q1 sales of $1.15B, plus or less 5%, behind analysts’ $1.36B. Marvell predicts adjusted gross margins of 62% to 63% and adjusted earnings of $0.18 to $0.28 per share, significantly below the average forecast of $0.40. Marvell announced $3B in stock buybacks.
Despite a 5.7% Y/Y rise, Costco Wholesale’s NASDAQ:COST shares plummeted roughly 4% as its FQ2 earnings reports fell short of the top-line estimate. Comparable sales increased by 5.6% during the quarter, above the 5.1% estimate.